Last reviewed · How we verify
NCT01734291
Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression
NA trial testing Family psychoeducation in Major Depressive Disorder in 49 participants. Completed in 9 October 2016.
20 June 2016
Quick facts
| Lead sponsor | Nagoya City University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 49 |
| Start date | 1 October 2012 |
| Primary completion | 20 June 2016 |
| Estimated completion | 9 October 2016 |
| Sites | 1 location across Japan |
Drugs / interventions tested
- Family psychoeducation
Conditions studied
- Major Depressive Disorder — all drugs for Major Depressive Disorder →
Sponsor
Nagoya City University
Who can join
Adults 18 to 85, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine the effectiveness of brief multifamily psychoeducation to relieve the psychological distress of families of patients with chronic major depression and to improve their family functioning.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Brief multifamily Psychoeducation for family members of patients with chronic major depression: a randomized controlled trial.
Katsuki F, Takeuchi H, Inagaki T, Maeda T, et al · · 2018 · cited 8× · PMID 29929495 · DOI 10.1186/s12888-018-1788-6 -
Multifamily psychoeducation for improvement of mental health among relatives of patients with major depressive disorder lasting more than one year: study protocol for a randomized controlled trial.
Katsuki F, Takeuchi H, Watanabe N, Shiraishi N, et al · · 2014 · cited 4× · PMID 25118129 · DOI 10.1186/1745-6215-15-320
Verify or expand the search:
- PubMed search for NCT01734291
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Major Depressive Disorder
Currently open trials in the same condition.
- NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
- NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
- NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting
Other Nagoya City University trials
Trials by the same sponsor.
- NCT07292207 — Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer · Phase 2 · not yet recruiting
- NCT07164976 — Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer · Phase 1, PHASE2 · recruiting
- NCT06542484 — The Real-world Treatment Satisfaction by Gefapixiant in RCC · NA · recruiting
- NCT06535893 — Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer · Phase 2 · recruiting
- NCT06663787 — Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Who Achieved Durable Response b · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01734291 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nagoya City University
- Last refreshed: 5 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01734291.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing